Skip to content

Cochliobolus Sativus Allergenic Extract

Published: July 26, 2026Updated: August 31, 2026

Cochliobolus Sativus Allergenic Extract is a diagnostic preparation derived from the Cochliobolus sativus fungus, used to test for hypersensitivity reactions in patients suspected of having mold allergies. This extract is administered as part of allergy testing procedures to identify specific environmental sensitivities, particularly relevant for individuals working in agricultural settings or those with respiratory symptoms triggered by fungal exposure.

Quick summary

A diagnostic allergenic extract used to identify hypersensitivity to the Cochliobolus sativus mold fungus.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 31, 2026Editorial policy

Key facts at a glance

RxNorm
852398
Generic
Cochliobolus Sativus Allergenic Extract
Class
unclassified
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
solution
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Used to diagnose allergic sensitization to Cochliobolus sativus, a common mold found in agricultural environments. Particularly useful for patients presenting with allergic rhinitis, asthma-like symptoms, or other respiratory reactions potentially triggered by exposure to this fungus in farming or grain-handling settings.

The extract contains allergenic proteins from Cochliobolus sativus. When applied to the skin (prick test) or administered via other diagnostic routes, it triggers an immune response in sensitized individuals, producing a localized reaction (wheal and flare) that confirms the presence of specific IgE antibodies against this mold.

For diagnostic use only by qualified healthcare professionals trained in allergy testing. Should be administered in a clinical setting equipped to manage potential anaphylactic reactions. Testing should be conducted when patients have discontinued antihistamines and other medications that may interfere with results. Positive results indicate sensitization but should be correlated with clinical history.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 31, 2026. · Read our editorial policy